European guideline for the management of hepatitis B and C virus infections.
Brook
M G
MG
gary.brook@nwlh.nhs.uk
D004797:Enzyme-Linked Immunosorbent Assay; D005060:Europe; D005260:Female; D006508:Hepatitis Antibodies / Q000302:isolation & purification; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000302:isolation & purification; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D012367:RNA, Viral / Q000302:isolation & purification; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015229:Sexually Transmitted Diseases, Viral / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
D006508:Hepatitis Antibodies; D006514:Hepatitis B Surface Antigens; D012367:RNA, Viral; D014761:Viral Hepatitis Vaccines; D007372:Interferons